Chemotherapy-Induced Peripheral Neuropathy: New Perspectives From the Bedside to the Bench
Charles L. Loprinzi, MD
Chemotherapy-induced peripheral neuropathy (CIPN) is a significant, debilitating complication of chemotherapy administration for cancer.
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2009 revision
Nadine Attal, MD, PhD
Initiated or caused by a primary lesion or dysfunction in the nervous system, neuropathic pain is a manifestation of multiple, heterogeneous disorders.
The War on Cancer Pain: New Battles
Judith A. Paice, PhD, RN
More effective surgical, chemotherapeutic, and radiologic therapies for cancer have increased overall survival rates.
Quantitative Sensory Testing and Mapping of Neuropathic Pain
David Walk, MD
Relatively simply and repeatable methods to quantify the sensory features of neuropathic pain are of critical importance for research and would complement current neurologic, musculoskeletal, and physical exams in the clinical setting.
- Acute and Post-Operative Pain
- Cancer-related Pain
- Chronic Noncancer Pain
- Comorbid Conditions
- Interventional Modalites
- Low Back Pain
- Medico-Legal-Ethical Issues
- Neuropathic Pain
- Nonopioid Pharmacotherapy
- Nonpharmacologic Treatment
- Opioid Pharmacotherapy
- Palliative Care
- Risk Management
- Scientific Perspectives
- Special Patient Populations
Continuing Education Activities
Professor of Neurology
Albany Medical College
Director, Comprehensive Pain Center
Albany Medical Center
Albany, New York
Douglas Schottenstein, MD, opened his own private practice so that he could deliver the highest quality of care in an advanced, self-contained center. He is one of only 200 physicians in the nation who is double-board certified in neurology and interventional pain management.
Dr Schottenstein and his expert staff at NY Spine Medicine treat patients suffering from a variety of acute and chronic painful conditions. Dr Schottenstein performs a variety of diagnostic and therapeutic procedures and surgeries, including epidurals, transforaminal nerve blocks, sympathetic blocks, facet and sacroiliac joint injections, radiofrequency lesioning, provocative discography, annuloplasty, nucleoplasty, spinal cord stimulation, and intrathecal pumps.
Dr Schottenstein received his interventional pain management training at Columbia University/New York Presbyterian Hospital, rated one of the top five hospitals in the nation. He received his neurology training at Emory University, the highest ranked department in the South, and one of the leading programs in the nation.
In addition to leading NY Spine Medicine, Dr Schottenstein is an attending physician at New York Presbyterian-affiliated hospitals, the top-rated hospital system in the region.
Dr Schottenstein is a highly active member of the American Academy of Neurology, the American Society of Anesthesiology, the American Society of Regional Anesthesia, the International Spine Intervention Society, and the American Society of Interventional Pain Physicians.
Continuing Education Activities
NY Spine Medicine
New York Presbyterian
New York, New York
Pain Res Manag. 2011...
Painful Diabetic Peripheral Neuropathy: Consensus Recommendations on Diagnosis, Assessment and Management.
A systematic literature review of psychological characteristics as determinants of outcome for spinal cord stimulation therapy.
Pain. 2010 Aug;150(2):284-9.
Quantitative Sensory Testing and Mapping: Nonautomated Quantitative Methods for Examination of the Patient With Neuropathic Pain
Clin J Pain. 2009 Sep;25(7):632-40....
EFNS Guidelines on the Pharmacological Treatment of Neuropathic Pain: 2009 Revision.
Eur J Neurol. 2010 Apr 9.
Background and objectives:...